ANCHORAGE, Alaska, Jan. 26, 2024 (GLOBE NEWSWIRE) — At the Board of Directors meeting held January 25, 2024, a cash dividend of $3.20 per share was declared, payable on March 15, 2024, to shareholders of record as of March 1, 2024.
CONTACT: Cheri Gillian
Secretary to the Board of Directors
907-777-3409
- ITULATEK® approved for treatment of children and adolescents in Canada - May 8, 2025
- CHESS Health’s eIntervention Named “Best Care Orchestration Platform” in 2025 MedTech Breakthrough Awards Program - May 8, 2025
- Notification of the Board of the Company about the intention to delist the shares of the Company from trading on the regulated market Nasdaq Vilnius AB - May 8, 2025